CME Group (CME) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $3.02
- Estimate
- $2.99
- Surprise
- +1.0%
- Revenue (period 2026-09-30)
- $1.74B
- Score at report (before → after)
- 4.9 → 4.9/10
Revenue source: xbrl.
How the report landed
CME Group (CME) beat the $2.99 estimate with adjusted EPS of $3.02 — a modest 1.0% upside surprise. TrendMatrix's engine moved from Buy (Wait) (4.9/10) to Hold at 4.9/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates CME Hold at 5.7/10.
3 of the last 4 quarters beat the estimate; this quarter's +1.0% surprise compares with a +1.1% four-quarter average. Next scheduled report: 2027-02-03.
What supports the rating
- V7 quality resilience bonus: +0.2 (Q=7.2 in RISK_OFF)
- Sector modifier (Financial Services): +1.0
What argues against it
- Analyst target reached - limited upside remaining
- Expensive valuation
- Target reached (-3.7% upside)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $296.42
- Stop
- $282.94
At 24.3× trailing and 22.4× forward earnings, consensus estimates imply little change in earnings power.
Model outputs from TrendMatrix’s engine as of 2026-10-30 — shown for context, not personalized investment advice.
CME at TrendMatrix's latest read
For financials, the EPS print is only half the story: credit costs, reserve builds, and rate sensitivity decide how a quarter actually lands.
- Industry
- Financial Data & Stock Exchanges
- Market cap
- $106.10B
- P/E (fwd)
- 22.4
- P/E (ttm)
- 24.3
- 52-week range
- $218.31–$329.16
- Off 52-week high
- 9.9%
- RSI (14)
- 65
- Volume vs avg
- 1.05×
- Score today
- 5.7/10